Here's Who May Have Been Crushed in Biogen's $18 Billion Plunge

(Bloomberg) -- Several large hedge funds are likely reeling Thursday after a failed study in Alzheimer’s disease erased more than $18 billion from Biogen Inc.’s market value.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.